Published in J Clin Oncol on February 08, 2010
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol (2014) 6.61
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol (2014) 6.10
Cost-effectiveness of Fluorine-18-Fluorodeoxyglucose positron emission tomography in tumours other than lung cancer: A systematic review. World J Radiol (2014) 0.82
Economic evaluation of nuclear medicine procedures. Eur J Nucl Med Mol Imaging (2010) 0.77
Peripheral blood lymphocyte to monocyte ratio recovery from low levels at diagnosis after completion of first line therapy predicts good clinical outcomes in patients with diffuse large B-cell lymphoma. Oncotarget (2017) 0.75
Utility of baseline, interim and end-of-treatment (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase. Sci Rep (2017) 0.75
FDG-PET imaging in hematological malignancies. Blood Rev (2016) 0.75
Systematic Review of Health Economic Evaluations of Diagnostic Tests in Brazil: How accurate are the results? Clinics (Sao Paulo) (2017) 0.75
The role of FDG-PET in Hodgkin lymphoma. Contemp Oncol (Pozn) (2017) 0.75
Saving costs in cancer patient management through molecular imaging. Eur J Nucl Med Mol Imaging (2017) 0.75
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging (2010) 7.82
Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med (2008) 4.71
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging (2014) 2.79
Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol (2012) 2.60
Chagas' cardiomyopathy: the economic burden of an expensive and neglected disease. Int J Cardiol (2013) 1.98
Epidemiology of pertussis. Pediatr Infect Dis J (2005) 1.84
Aphasic or amnesic status epilepticus detected on PET but not EEG. Epilepsia (2008) 1.81
Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg (2004) 1.77
A structured review of studies on health-related quality of life and economic evaluation in pediatric acute lymphoblastic leukemia. J Natl Cancer Inst Monogr (2004) 1.63
SNM practice guideline for sodium 18F-fluoride PET/CT bone scans 1.0. J Nucl Med (2010) 1.63
Myocardial perfusion imaging is a strong predictor of death in women. JACC Cardiovasc Imaging (2011) 1.45
Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol (2005) 1.43
PET myocardial glucose metabolism and perfusion imaging: Part 1-Guidelines for data acquisition and patient preparation. J Nucl Cardiol (2003) 1.39
Magnification chromoendoscopy for the diagnosis of gastric intestinal metaplasia and dysplasia. Gastrointest Endosc (2003) 1.39
Joint guidance on peptide receptor radionuclide therapy in neuroendocrine tumors. J Nucl Med (2013) 1.38
EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med (2013) 1.37
Diagnostic accuracy of level 3 portable sleep tests versus level 1 polysomnography for sleep-disordered breathing: a systematic review and meta-analysis. CMAJ (2013) 1.32
18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma. J Nucl Med (2010) 1.31
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer. J Natl Compr Canc Netw (2007) 1.26
NCCN task force: clinical utility of PET in a variety of tumor types. J Natl Compr Canc Netw (2009) 1.24
Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations. Pediatr Infect Dis J (2005) 1.22
Localized cerebral blood flow reductions in patients with heart failure: a study using 99mTc-HMPAO SPECT. J Neuroimaging (2005) 1.20
Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med (2004) 1.17
Germline MUTYH (MYH) mutations in Portuguese individuals with multiple colorectal adenomas. Hum Mutat (2004) 1.14
The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Am Surg (2003) 1.12
Clinical validation of SPECT attenuation correction using x-ray computed tomography-derived attenuation maps: multicenter clinical trial with angiographic correlation. J Nucl Cardiol (2005) 1.12
Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol (2006) 1.09
SNM practice guideline for hepatobiliary scintigraphy 4.0. J Nucl Med Technol (2010) 1.07
Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma. J Pediatr Hematol Oncol (2006) 1.07
SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med (2013) 1.04
Cerebral lesions incidentally detected on 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography images of patients evaluated for body malignancies. Mol Imaging Biol (2002) 1.02
Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice. Int J Cardiol (2005) 1.02
Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab (2007) 1.01
Emergency ureteroscopic management of ureteral stones: why not? Urology (2007) 1.01
Surgical treatment of penile duplication. J Pediatr Urol (2010) 0.98
CT-based attenuation correction versus prone imaging to decrease equivocal interpretations of rest/stress Tc-99m tetrofosmin SPECT MPI. J Nucl Cardiol (2007) 0.97
Brazilian consensus in gastric cancer: guidelines for gastric cancer in Brazil. Arq Bras Cir Dig (2013) 0.96
Endoscopic assessment and grading of Barrett's esophagus using magnification endoscopy and narrow-band imaging: accuracy and interobserver agreement of different classification systems (with videos). Gastrointest Endosc (2011) 0.95
The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries. J Nucl Med (2009) 0.92
An algorithm for longitudinal registration of PET/CT images acquired during neoadjuvant chemotherapy in breast cancer: preliminary results. EJNMMI Res (2012) 0.92
A premenopausal woman with virilization secondary to an ovarian Leydig cell tumor. Nat Rev Endocrinol (2011) 0.90
Frontal Localization of Absence Seizures Demonstrated by Ictal Positron Emission Tomography. Epilepsy Behav (2001) 0.89
Indoor climbing elicits plasma oxidative stress. Med Sci Sports Exerc (2007) 0.89
A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F]fluoro-2-deoxy-D-glucose: role of primary tumor variables. J Am Coll Surg (2008) 0.88
Endoscopic assessment and grading of Barrett's esophagus using magnification endoscopy and narrow band imaging: impact of structured learning and experience on the accuracy of the Amsterdam classification system. Scand J Gastroenterol (2012) 0.87
Oxidative stress in humans during and after 4 hours of hypoxia at a simulated altitude of 5500 m. Aviat Space Environ Med (2004) 0.87
Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer. Clin Nucl Med (2010) 0.87
Dietary strategies to recover from exercise-induced muscle damage. Int J Food Sci Nutr (2013) 0.86
2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography uptake in a giant adrenal myelolipoma. Mol Imaging Biol (2002) 0.85
Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions. Clin Lymphoma Myeloma Leuk (2011) 0.85
Economic burden of pertussis and the impact of immunization. Pediatr Infect Dis J (2005) 0.84
Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG positron emission tomography and bone scintigraphy. Clin Nucl Med (2003) 0.84
[Penile abscess. Case report]. Arch Esp Urol (2006) 0.84
Adenoma incidence decreases under the effect of polypectomy. World J Gastroenterol (2012) 0.82
Effect of off-road competitive motocross race on plasma oxidative stress and damage markers. Br J Sports Med (2006) 0.82
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose for initial staging of hodgkin lymphoma: a single center experience in Brazil. Clinics (Sao Paulo) (2009) 0.81
[18F]Fluorodeoxyglucose positron emission tomography surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case report. Am Surg (2003) 0.81
Hand-carried ultrasound units for point-of-care cardiac examinations. Issues Emerg Health Technol (2002) 0.81
Metabolic test with fluorine-18-fluorodeoxyglucose in staging and detection of residual tumor or recurrence in Hodgkin lymphoma. Clinics (Sao Paulo) (2007) 0.81
Exercise and cardiac oxidative stress. Rev Port Cardiol (2003) 0.80
Cardiac resynchronization therapy evaluated by myocardial scintigraphy with 99mTc-MIBI: changes in left ventricular uptake, dyssynchrony, and function. Eur J Nucl Med Mol Imaging (2009) 0.80
Serendipitous detection of Cushing's disease by FDG positron emission tomography and a review of the literature. Clin Nucl Med (2002) 0.80
New imaging tools for the diagnosis of infection. Future Microbiol (2007) 0.80
SNM general and hybrid imaging guidelines. J Nucl Med (2010) 0.79
The role of surgeons in identifying emerging technologies for health technology assessment. Can J Surg (2010) 0.78
Doppler flow evaluation can anticipate abnormal left lung perfusion after transcatheter closure of patent ductus arteriosus. Eur Heart J (2004) 0.78
Incremental value of fusion imaging with integrated PET-CT in oncology. Clin Nucl Med (2005) 0.78
Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine, and neural crest tumors. Clin Nucl Med (2004) 0.78
FDG PET in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy. Int J Radiat Oncol Biol Phys (2003) 0.78
Hodgkin lymphoma among patients infected with HIV in post-HAART era. Clin Lymphoma Myeloma (2007) 0.78
Gender differences in ventricular volumes and left ventricle ejection fraction estimated by myocardial perfusion imaging: comparison of Quantitative Gated SPECT (QGS) and Segami software programs. Arq Bras Cardiol (2007) 0.77
Phase contrast X-ray synchrotron imaging for assessing external and internal morphology of Rhodnius prolixus. Appl Radiat Isot (2011) 0.77
Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. J Am Coll Radiol (2005) 0.77
Gammadelta and alphabeta T-cell acute lymphoblastic leukemia: comparison of their clinical and immunophenotypic features. Haematologica (2005) 0.76
I Diretriz sobre Aspectos Específicos de Diabetes (tipo 2) Relacionados à Cardiologia. Arq Bras Cardiol (2014) 0.76
The impact of normalization and segmentation on resting-state brain networks. Brain Connect (2015) 0.76
Evaluation of surgical treatment of congenital heart disease in patients aged above 16 years. Arq Bras Cardiol (2012) 0.76
Calcium channel blockers: a potential cause of false-positive captopril renography. Clin Nucl Med (2003) 0.76
Positron emission tomography for evaluation of colorectal carcinoma. Semin Roentgenol (2002) 0.76
Positron emission tomography/computed tomography of a rare xanthogranulomatous process: Erdheim-Chester disease. Mol Imaging Biol (2004) 0.75
TBNA or EBUS-TBNA? That is the question. Arch Bronconeumol (2011) 0.75
Re: "integrated residency training pathways of the future: diagnostic radiology, nuclear radiology, nuclear medicine, and molecular imaging". J Am Coll Radiol (2012) 0.75
Addendum to the editorial "Joint guidance on peptide receptor radionuclide therapy in neuroendocrine tumors". J Nucl Med (2013) 0.75